1.55
-0.05(-3.13%)
Currency In USD
| Previous Close | 1.6 |
| Open | 1.59 |
| Day High | 1.61 |
| Day Low | 1.54 |
| 52-Week High | 4.98 |
| 52-Week Low | 1.35 |
| Volume | 552,194 |
| Average Volume | 2.22M |
| Market Cap | 92.92M |
| PE | -1.23 |
| EPS | -1.26 |
| Moving Average 50 Days | 2.34 |
| Moving Average 200 Days | 2.83 |
| Change | -0.05 |
If you invested $1000 in Eledon Pharmaceuticals, Inc. (ELDN) 10 years ago, it would be worth $1.09 as of December 30, 2025 at a share price of $1.55. Whereas If you bought $1000 worth of Eledon Pharmaceuticals, Inc. (ELDN) shares 5 years ago, it would be worth $103.33 as of December 30, 2025 at a share price of $1.55.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
GlobeNewswire Inc.
Dec 01, 2025 12:00 PM GMT
IRVINE, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer will participate in a fireside chat at the upcoming 37th Annual Pip
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
GlobeNewswire Inc.
Nov 18, 2025 9:05 PM GMT
IRVINE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted at the University of Chicago Medicine’s Transplant Institute
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire Inc.
Nov 12, 2025 12:56 PM GMT
IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced the pricing of its underwritten public offering of (i) 15,152,485 shares of its common stock at a public offering price of $1.